share_log

BTIG Initiates Coverage On ProMIS Neurosciences With Buy Rating, Announces Price Target of $8

BTIG Initiates Coverage On ProMIS Neurosciences With Buy Rating, Announces Price Target of $8

BTIG以买入评级开始对ProMis Neurosciences进行报道,宣布目标股价为8美元
Benzinga ·  2023/10/03 04:43

BTIG analyst Thomas Shrader initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating and announces Price Target of $8.

BTIG分析师Thomas Shrader在PROMIS神经科学(纳斯达克:PMN)上发起报道,评级为买入,并宣布目标价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发